Thuja Capital

Thuja Capital is a Netherlands-based venture capital firm that backs early-stage health care and biotech companies. Founded in 2006 and based in Utrecht, the firm focuses on medical devices, diagnostics, therapeutics, digital health, nutraceuticals, and related platform technologies. It typically provides seed and start-up financing as well as bridge and early equity or debt investments, and aims to act as lead or co-investor while taking a supervisory board seat in portfolio companies. The geographic focus spans the Benelux region and Western Europe. The firm supports companies developing bio pharmaceuticals, novel formulations, and technologies across life sciences to address diagnosis, treatment, care, or prevention.

Evan Castiglia

Partner

Tyler Hayes MD

Principal

Past deals in Rotterdam

Pan Cancer

Seed Round in 2024
Pan-Cancer T is a biotechnology spin-out from Erasmus MC, Rotterdam, the Netherlands dedicated to discovering and developing T cell receptor (TCR) T cell therapies. The company exploits 20 years of pioneering research in the field of adoptive T-cell therapies. This foundation serves as a springboard towards breakthrough therapies for solid tumors.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.